The nose is a primary reservoir for bacteria and viruses that can cause illness.
Killing germs at the source—the nose—has been clinically proven to help reduce infection risk.
- Federal policymakers can play a pivotal role in advancing nasal sanitization as a public health infection prevention strategy.
- Many harmful pathogens, including COVID-19, have been efficiently inactivated by alcohol-based hand rub formulations in vitro, leading to WHO and CDC recommending the use of commercially available topical antiseptics in health care systems and during viral outbreaks. However, no topical antiseptics, including hand sanitizers, are approved by the FDA to prevent or treat COVID-19.
- Despite following the same FDA regulations as hand sanitizer, alcohol-based nasal antiseptics have yet to be recommended by CDC and WHO as an infection prevention practice for the public.
Sanitize Your Nose advisors’ recommendations to CDC:
- CDC should test alcohol-based nasal antiseptic formulations just as they have tested hand sanitizers for use in viral outbreaks.
- CDC should recommend use of nasal antiseptic formulations in public health guidelines along with hand sanitizers
Broad adoption of hand sanitizing with alcohol-based solutions took place only 20 years ago.
Policymakers should learn from this and help accelerate the adoption of nasal sanitization.
CONTACT US TO LEARN MORE
You can find answers fast by reviewing our Frequently Asked Questions, and if you would like more information we invite you to submit your inquiry below.